Abstract
Acute lymphoblastic leukemia (ALL) has become a curable disease through the development of effective treatment strategies based on polychemotherapy with non-crossresistant drugs, effective prophylaxis of central nervous system leukemia, and prolonged maintenance chemotherapy [1–4]. Lymhoblastic leukemia in children, in particular, has been treated successfully, with the majority of children surviving 5 years [5]. It was recognized during the early studies that patients had very different responses to standard therapy, and a number of models were developed to identify patient groups with different prognoses. As a consequence, children with ALL were treated differently, based on their classification as “low,”-“standard,”- or “high”-risk patients. Risk group assignments were mainly based on age, white blood cell count (WBC), and involvement of lymph nodes, hepatomegaly or splenomegaly in some series [5].
Supported in part by grants from the NIH CA-38980, CA-20194, and CA-05826.
Preview
Unable to display preview. Download preview PDF.
References
Schauer P, Arlin ZA, Mertelsmann R, Cirrincione C, Friedman A, Gee T, Dowling M, Kempin S, Straus DJ, Koziner B, McKenzie S, Thaler HT, Dufour P, Little C, Dellaquila C, Ellis S, Clarkson B (1983) Treatment of acute lymphoblastic leukemia in adults: results of the L-10 and L-10M protocols. J Clin Oncol 1: 462–470
Clarkson B, Gee T, Arlin Z, Mertelsmann R, Kempin S, Dinsmore R, O’Reilly R, Andreeff M, Berman E, Higgins C, Little C, Cirrincione C, Ellis S (1984) Current status of treatment of acute leukemia in adults: an overview. In: Buechner Th (ed) Therapy of Acute Leukemia. Springer, Berlin Heidelberg New York Tokyo, pp 1–31
Clarkson B, Ellis S, Little C, Gee T, Arlin Z, Mertelsmann R, Andreeff M, Kempin S, Koziner B, Chaganti R, Jhanwar S, McKenzie S, Cirrincione C, Gaynor J (1985) Acute lymphoblastic leukemia in adults. Semin On-col 12: 160–179
Hoelzer D, Thiel E, Loeffler H, Bodenstein H, Plaumann L, et al. (1984) Intensified therapy in acute lymphoblastic and acute undifferenti-ated leukemia in adults. Blood 64: 38–47
Riehm H, Gadner H, Henze G, Kornhuber B, Langermann H-J, Mueller-Weihrich S and Schellong G (1983) Acute lymphoblastic leukemia: treatment results in three BFM studies (1970–1981). In: Murphy SB, Gilbert JR (eds) Leukemia research: advances in cell biology and treatment. Elsevier Science, New York, pp 251–260 20.
Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, Sultan C (FAB Cooperative Group) (1976) Proposals for the classification of the acute leukaemias. Br J Haemat 33: 415
Jhanwar S, Conjalka M, Chaganti R, et al. (to be published) Cytogenetic analysis and prognostic correlations in acute lymphoblastic leukemia (ALL) in adults and children
Andreeff M, Darzynkiewicz Z, Sharpless TK, Clarkson B, Melamed MR (1980) Discrimination of human leukemia subtypes by flow cytometric analysis of cellular DNA and RNA. Blood 55: 282–293
Hiddemann W, Schumann J, Andreeff M, Barlogie B, Herman C, Leif RC, Mayall BH, Murphy RF, Sandberg AA (1984) Convention on nomenclature for DNA cytometry. Cytometry 5: 445–446
Andreeff M, Redner A, Thongprasert S, Eagle B, Steinherz P, Miller D, Melamed MR (1985) Multiparameter flow cytometry for determination of ploidy, proliferation and differentiation in acute leukemia: treatment effects and prognostic value. In: Buechner Th (ed) Tumor aneuploidy. Springer Berlin Heidelberg New York Tokyo, pp 81–105
Andreeff M, Assing G, Cirrincione C (1986) Prognostic value of DNA/RNA flow cytometry in myeloblastic and lymphoblastic leukemia in adults: RNA content and S-phase predict remission duration and survival in multivariate analysis. In: Andreeff M (ed) Clinical cytometry. (ed) Ann NY Acad Sci 468: 387–406
Cox DR (1972) Regression models and life tables (with discussion). J R Stat Soc B 34: 187–220
BMDP Statistical Software (1983) University of California Press. Berkeley, CA
Kalbfleisch JD, Prentice RL (1980) The statistical analysis of failure time data. Wiley, New York, pp 39–69 29.
Cox DR (1975) Partial likelihood. Biometrika 62: 269–276
Mantel N (1966) Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 30. 50: 163–170
Peto R, Peto J (1972) Asympotically efficient rank invariant test procedures. J R Stat Soc A 135: 185–206
Kaplan EL, Meier P (1958) Nonparametric estimation from incomplete observations. J Am Stat Assoc 53: 457–481
Afifi AA, Elashoff RM (1966) Missing observations in multivariate statistics. I. Review of the literature. J Am Stat Assoc 61:595–605 Afifi AA, Elashoff RM (1967) Missing observations in multivariate statistics. II. Point estimation in simple linear regression. J Am Stat Assoc 62: 10–29
Afifi AA, Elashoff RM (1969) Missing observations in multivariate statistics. III. Large sample analysis of simple linear regression. J Am Stat Assoc 64: 337–358
Afifi AA, Elashoff RM (1967) Missing observations in mulitvariate statistics. III. Large sample analysis of simple linear regression.J Am Stat Assoc 64: 337–358
Gaynor J, Chapman D, Little C, Andreeff M, Gee T, Clarkson B (to be published) A cause-specific hazard rate analysis of prognostic factors among adult patients with Acute Lymphoblastic Leukemia (ALL): The Memorial Hospital Experience
Darzynkiewicz Z, Traganos F, Staiano-Coico L (1986) Cell and nuclear growth during G1: kinetic and clinical implications. In: Andreeff M (ed) Clinical cytometry. Ann NY Acad Sci 468: 45–54
Redner A, Andreeff M, Bagin R, Miller DR, Groshen S (1984) RNA content predicts early response in pediatric ALL: multivariate analysis of prognostic factors. Blood [Suppl] 64: 149a
Espiritu E, Welte K, Andreeff M (1985) Induction of Leu-11 on lymphoid leukemic cells by OKT3, PMA and IL-2. Proc Intl Conf Analyt Cytol 11: 355
Welte K, Andreeff M, Platzer E, Holloway K, Rubin BY, Moore MAS, Mertelsmann R (1984) Interleukin 2 regulates the expression of Tac antigen on peripheral blood T lymphocytes. J Exp Med 160: 1390–1403
Hart JS, George SL, Frei E III, Bodey GP, Nickerson RC, Freireich EJ (1977) Prognostic significance of pretreatment proliferative activity in adult acute leukemia. Cancer 39: 1603
Scarffe JH, Hann IM, Evans DI, Jones PH, Palmer MK, Lilleyman JS, Crowther D (1980) Relationship between the pretreatment proliferative activity of marrow blast cells and prognosis of acute lymphoblastic leukaemia of childhood. Br J Cancer 41: 764–770
Dow LW, Chang LJA, Tsiatis AA, Melvin SL, Bowman WP (1982) Relationship of pretreatment lymphoblast proliferative activity and prognosis in 97 children with acute lymphoblastic leukemia. Blood 59: 1197–1202
Murphy SB, Melvin SL, Mauer AM (1979) Correlation of tumor cell kinetic studies with surface marker results in childhood non-Hodgkins lymphoma. Cancer Res 39: 15341538
Baccarani M, Corbelli G, Amadori S, Drenthe-Schonk A, Willemze R, Meloni G, Cardozo PL, Haanen C, Mandelli F, Turu S (1982) Adolescent and adult acute lymphoblastic leukemia: prognostic features and outcome of therapy. A study of 293 patients. Blood 60: 677–684
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1987 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Andreeff, M., Gaynor, J., Chapman, D., Little, C., Gee, T., Clarkson, B.D. (1987). Prognostic Factors in Acute Lymphoblastic Leukemia in Adults: The Memorial Hospital Experience. In: Büchner, T., Schellong, G., Hiddemann, W., Urbanitz, D., Ritter, J. (eds) Acute Leukemias. Haematology and Blood Transfusion / Hämatologie und Bluttransfusion, vol 30. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-71213-5_18
Download citation
DOI: https://doi.org/10.1007/978-3-642-71213-5_18
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-16556-9
Online ISBN: 978-3-642-71213-5
eBook Packages: Springer Book Archive